{
    "doi": "https://doi.org/10.1182/blood.V106.11.675.675",
    "article_title": "Rituximab-Supplemented High-Dose Sequential Chemotherapy (HDS) Has Superior Response Rate and Event-Free Survival (EFS) Compared to R-CHOP in Poor Risk Follicular Lymphoma (FL) at Diagnosis: Results from a Multicenter Randomized GITMO Trial. ",
    "article_date": "November 16, 2005",
    "session_type": "Oral Sessions",
    "abstract_text": "Introduction. HDS with autografting has proved to be effective (Corradini et al, J Clin Oncol 2004) and feasible at the multicenter level in FL (Ladetto et al, Blood 2002); in addition, it can be successfully combined with Rituximab (R-HDS) (Magni et al, Blood 2000). Aim of this trial was to compare R-HDS with Rituximab-supplemented CHOP (R-CHOP) in poor risk FL patients (pts) younger than 60 years. Patients and methods. Between January 2000 and March 2005, 136 patients have been randomized (68 in each arm). Patients were stratified according to histology (grade I or II 101, grade III 35). Patients were eligible if they had an age-adjusted IPI \u22652 (125 pts) or, in the absence of this criterion if they had three or more adverse parameters according to the Italian Lymphoma Intergroup score (11 pts). Clinical features were: median age 50 yrs. (22\u201360), stage III-IV 98%, elevated LDH 78%, bulky disease 66%, B symptoms 47%, extranodal disease (other than BM) 45%, leukemic disease 11%, ECOG PS >1 47%. R-HDS consisted of: i. 2 APO and 2 DHAP courses; ii. sequential administration of Etoposide (2 g/sqm), 2 Rituximab, Cyclophosphamide (Cy) (7g/sqm) with PBPC collection (in vivo-purged with two Rituximab on day 1 and 11 post Cy); iii. Mitoxantrone (60mg/sqm) + L-Pam (180mg/sqm) with autografting (5\u20138x10 6 CD34+ cells/kg). R-CHOP consisted of 6 CHOP courses followed by 4\u20136 doses of Rituximab as originally reported (Rambaldi et al, Blood 2002). Cross-over was allowed for patients failing R-CHOP. Minimal residual disease analysis with the bcl-2/IgH was planned on BM cells. Patients were assessed on an \u201cintention to treat\u201d basis. Results. The two treatments arms were well balanced for all the previously described clinical parameters. 68% patients were able to conclude R-CHOP (failure due to progression 29% and toxicity 3%) and 78% R-HDS (failure due to progression 9%, toxicity 5%, poor mobilization 4 %, refusal 4%). Toxic deaths were 4 (2 in each arms); in addition 1 gastric cancer and 1 AML occurred in the R-HDS group. Progressions and non-responders were 35% in the R-CHOP arm and 13% in the R-HDS (p<0.05) with 53% and 82% CR rates, respectively. Current median follow-up is 24 months. Event-free survival (EFS) at 24 months is 41% for the R-CHOP arm and 66% for the R-HDS arm (p< .001). At present there is no difference in terms of OS. We currently have data on salvage treatment in 22 patients failing R-CHOP: 16 of them were treated with R-HDS, with 10 achieving CR. A molecular marker was available in 72% of patients. PCR results at follow-up are available in 27 patients. Molecular remission, defined as two PCR-negative BM samples taken at six months intervals, was observed in 54% of R-CHOP and 77% of R-HDS patients. Conclusions. R-HDS induces a greater number of CR and ensures a better EFS compared to R-CHOP in this rare and extremely aggressive population of high-risk FL patients. It is unknown if these results reflect a peculiar behaviour of high-risk patients or can be relevant for all younger FCL patients with advanced disease requiring cytoreductive treatments.",
    "topics": [
        "chemotherapy regimen",
        "follicular lymphoma",
        "r-chop",
        "rituximab",
        "brachial plexus neuritis",
        "cyclophosphamide, doxorubicin, prednisone, and vincristine",
        "follow-up",
        "polymerase chain reaction",
        "toxic effect",
        "biological markers"
    ],
    "author_names": [
        "Marco Ladetto, MD",
        "Irene Ricca, MD",
        "Fabio Benedetti, MD",
        "Umberto Vitolo, MD",
        "Caterina Patti, MD",
        "Alessandro Rambaldi, MD",
        "Anna Marina Liberati, MD",
        "Maurizio Musso, MD",
        "Alessandro Pulsoni, MD",
        "Attilio Olivieri, MD",
        "Enzo Pavone, MD",
        "Enrico Pogliani, MD",
        "Delia Rota Scalabrini, MD",
        "Andrea Gallamini, MD",
        "Vincenzo Callea, MD",
        "Barbara Mantoan, PhD",
        "Mario Boccadoro, MD",
        "Ignazio Majolino, MD",
        "Paolo Corradini, MD",
        "Alessandro M. Gianni, MD",
        "Corrado Tarella, MD"
    ],
    "author_dict_list": [
        {
            "author_name": "Marco Ladetto, MD",
            "author_affiliations": [
                "On Behalf of the GITMO, (Gruppo Italiano Trapianto di Midollo Osseo), Italy"
            ],
            "author_rank": 1,
            "first_author": 1,
            "last_author": 0
        },
        {
            "author_name": "Irene Ricca, MD",
            "author_affiliations": [
                "On Behalf of the GITMO, (Gruppo Italiano Trapianto di Midollo Osseo), Italy"
            ],
            "author_rank": 2,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Fabio Benedetti, MD",
            "author_affiliations": [
                "On Behalf of the GITMO, (Gruppo Italiano Trapianto di Midollo Osseo), Italy"
            ],
            "author_rank": 3,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Umberto Vitolo, MD",
            "author_affiliations": [
                "On Behalf of the GITMO, (Gruppo Italiano Trapianto di Midollo Osseo), Italy"
            ],
            "author_rank": 4,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Caterina Patti, MD",
            "author_affiliations": [
                "On Behalf of the GITMO, (Gruppo Italiano Trapianto di Midollo Osseo), Italy"
            ],
            "author_rank": 5,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Alessandro Rambaldi, MD",
            "author_affiliations": [
                "On Behalf of the GITMO, (Gruppo Italiano Trapianto di Midollo Osseo), Italy"
            ],
            "author_rank": 6,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Anna Marina Liberati, MD",
            "author_affiliations": [
                "On Behalf of the GITMO, (Gruppo Italiano Trapianto di Midollo Osseo), Italy"
            ],
            "author_rank": 7,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Maurizio Musso, MD",
            "author_affiliations": [
                "On Behalf of the GITMO, (Gruppo Italiano Trapianto di Midollo Osseo), Italy"
            ],
            "author_rank": 8,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Alessandro Pulsoni, MD",
            "author_affiliations": [
                "On Behalf of the GITMO, (Gruppo Italiano Trapianto di Midollo Osseo), Italy"
            ],
            "author_rank": 9,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Attilio Olivieri, MD",
            "author_affiliations": [
                "On Behalf of the GITMO, (Gruppo Italiano Trapianto di Midollo Osseo), Italy"
            ],
            "author_rank": 10,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Enzo Pavone, MD",
            "author_affiliations": [
                "On Behalf of the GITMO, (Gruppo Italiano Trapianto di Midollo Osseo), Italy"
            ],
            "author_rank": 11,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Enrico Pogliani, MD",
            "author_affiliations": [
                "On Behalf of the GITMO, (Gruppo Italiano Trapianto di Midollo Osseo), Italy"
            ],
            "author_rank": 12,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Delia Rota Scalabrini, MD",
            "author_affiliations": [
                "On Behalf of the GITMO, (Gruppo Italiano Trapianto di Midollo Osseo), Italy"
            ],
            "author_rank": 13,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Andrea Gallamini, MD",
            "author_affiliations": [
                "On Behalf of the GITMO, (Gruppo Italiano Trapianto di Midollo Osseo), Italy"
            ],
            "author_rank": 14,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Vincenzo Callea, MD",
            "author_affiliations": [
                "On Behalf of the GITMO, (Gruppo Italiano Trapianto di Midollo Osseo), Italy"
            ],
            "author_rank": 15,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Barbara Mantoan, PhD",
            "author_affiliations": [
                "On Behalf of the GITMO, (Gruppo Italiano Trapianto di Midollo Osseo), Italy"
            ],
            "author_rank": 16,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Mario Boccadoro, MD",
            "author_affiliations": [
                "On Behalf of the GITMO, (Gruppo Italiano Trapianto di Midollo Osseo), Italy"
            ],
            "author_rank": 17,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Ignazio Majolino, MD",
            "author_affiliations": [
                "On Behalf of the GITMO, (Gruppo Italiano Trapianto di Midollo Osseo), Italy"
            ],
            "author_rank": 18,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Paolo Corradini, MD",
            "author_affiliations": [
                "On Behalf of the GITMO, (Gruppo Italiano Trapianto di Midollo Osseo), Italy"
            ],
            "author_rank": 19,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Alessandro M. Gianni, MD",
            "author_affiliations": [
                "On Behalf of the GITMO, (Gruppo Italiano Trapianto di Midollo Osseo), Italy"
            ],
            "author_rank": 20,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Corrado Tarella, MD",
            "author_affiliations": [
                "On Behalf of the GITMO, (Gruppo Italiano Trapianto di Midollo Osseo), Italy"
            ],
            "author_rank": 21,
            "first_author": 0,
            "last_author": 1
        }
    ],
    "datetime_abstract_obtained": "2022-04-28T21:28:42",
    "is_scraped": "1"
}